Cargando…
Race reporting and diversity in US food and drug administration (FDA) registration trials for prostate cancer; 2006–2020
BACKGROUND: There is significant racial disparity in prostate cancer (PCa) in terms of incidence, treatment, and outcomes. Racial diversity and compliance with FDA race reporting guidelines in PCa drug registration trials are unknown. We analyzed racial diversity and race reporting in drug licensing...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616766/ https://www.ncbi.nlm.nih.gov/pubmed/33859363 http://dx.doi.org/10.1038/s41391-021-00361-0 |